79386701 - NORDIC PROTEINFINGERPRINT TECHNOLOGY

Information

  • Trademark
  • 79386701
  • Serial Number
    79386701
  • Filing Date
    September 19, 2023
    a year ago
  • Transaction Date
    November 25, 2024
    28 days ago
  • Status Date
    November 25, 2024
    28 days ago
  • Location Date
    November 25, 2024
    28 days ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 109
    Employee Name
    BIBB, SCOTT
  • Attorney Name
    Bradley M. Stohry
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4
Mark Identification
NORDIC PROTEINFINGERPRINT TECHNOLOGY
Case File Statements
  • GS0051: Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use
  • PM0001: NORDIC PROTEIN FINGERPRINT TECHNOLOGY
  • GS0421: Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis for medical and pharmaceutical research services; advice, information and assistance relating to the foregoing
Case File Event Statements
  • 1/4/2024 - 11 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/5/2024 - 11 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/9/2024 - 11 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/25/2024 - 9 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/2/2024 - 7 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/3/2024 - 7 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/9/2024 - 2 months ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/9/2024 - 7 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/9/2024 - 7 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/28/2024 - 6 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/9/2024 - 2 months ago
    10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/9/2024 - 2 months ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/9/2024 - 2 months ago
    14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/9/2024 - 2 months ago
    11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/25/2024 - 28 days ago
    15 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 11/25/2024 - 28 days ago
    16 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2